Surgical treatment of dyskinesia in Parkinson's disease

Frontiers in Neurology

Volumn 5 APR, Issue , 2014, Pages

  Munhoz, Renato P ^a   Cerasa, Antonio ^b,c   Okun, Michael S ^d  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Institute of Molecular Bioimaging and Physiology   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

DBS; Deep brain stimulation; Dyskinesia; Pallidotomy; Parkinson's disease

Indexed keywords

LEVODOPA;

ABLATION THERAPY; BRAIN DEPTH STIMULATION; COGNITION; DOPAMINERGIC SYSTEM; DYSKINESIA; GLOBUS PALLIDUS; HUMAN; INTERMETHOD COMPARISON; PALLIDOTOMY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; REVIEW; SLEEP; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 84901014445     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00065     Document Type: Review

References (73)

1. Follett KA. Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesia. Neurosurg Focus (2004) 17:E3. doi: 10.3171/foc.2004.17.1.3.
2. Guridi J, Lozano AM. A brief history of pallidotomy. Neurosurgery (1997) 41:1169-80. doi:10.1097/00006123-199711000-00029.
3. Cooper IS. Surgical alleviation of Parkinsonism; effects of occlusion of the anterior choroidal artery. J Am Geriatr Soc (1954) 2:691-718.
4. Rand RW, Stern WE, Orr JK. Parkinsonism; early results of occlusion of the anterior choroidal artery. Calif Med (1954) 81:276-8.
5. Gillingham J. Forty-five years of stereotactic surgery for Parkinson's disease: a review. Stereotact Funct Neurosurg (2000) 74:95-8. doi:10.1159/000056469.
6. Okun MS, Vitek JL. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord (2004) 19:375-89. doi:10.1002/mds.20037.
7. Speelman JD, Bosch DA. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord (1998) 13:582-8. doi:10.1002/mds.870130336.
8. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med (1998) 339:1130-43. doi:10.1056/NEJM199810153391607.
9. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol (1983) 46:68-83.
10. Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Scand (1960) 35:358-77. doi:10.1111/j.1600-0447.1960.tb07606.x.
11. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg (1992) 76:53-61. doi:10.3171/jns.1992.76.1.0053.
12. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science (1990) 249:1436-8. doi:10.1126/science.2402638.
13. Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg (1992) 6:575-82. doi:10.3109/02688699209002375.
14. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol (1992) 68:1859-66.
15. Lozano AM, Lang AE. Pallidotomy for Parkinson's disease. Adv Neurol (2001) 86:413-20.
16. Lang AE, Lozano AM, Montgomery E, DuffJ, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med (1997) 337:1036-42. doi:10.1056/NEJM199710093371503.
17. Fine J, DuffJ, Chen R, Chir B, Hutchison W, Lozano AM, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 342:1708-14. doi:10.1056/NEJM200006083422304.
18. Samuel M, Caputo E, Brooks DJ, Schrag A, Scaravilli T, Branston NM, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain (1998) 121:59-75. doi:10.1093/brain/121.1.59.
19. Vitek JL, Bakay RA, Freeman A, Evatt M, Green J, McDonald W, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol (2003) 53:558-69. doi:10.1002/ana.10517.
20. Kleiner-Fisman G, Lozano A, Moro E, Poon YY, Lang AE. Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia. Mov Disord (2010) 25:1496-8. doi:10.1002/mds.23155.
21. Hariz MI, Bergenheim AT. A 10-year follow-up review of patients who underwent Leksell's posteroventral pallidotomy for Parkinson disease. J Neurosurg (2001) 94:552-8. doi:10.3171/jns.2001.94.4.0552.
22. Goodman SH, Wilkinson S, Overman J, Koller WC, Tröster A, Pahwa R, et al. Lesion volume and clinical outcome in stereotactic pallidotomy and thalamotomy. Stereotact Funct Neurosurg (1998) 71:164-72. doi:10.1159/000029660.
23. Gross RE, Lombardi WJ, Lang AE, DuffJ, Hutchison WD, Saint-Cyr JA, et al. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain (1999) 122:405-16. doi:10.1093/brain/122.3.405.
24. Pincus MM. Beneficial effect of bilateral pallidotomy on gait is unproven. Arch Neurol (2000) 57:1231-2. doi:10.1001/archneur.57.8.1231.
25. Siegel KL, Metman LV. Effects of bilateral posteroventral pallidotomy on gait of subjects with Parkinson disease. Arch Neurol (2000) 57:198-204. doi:10.1001/archneur.57.2.198.
26. Intemann PM, Masterman D, Subramanian I, DeSalles A, Behnke E, Frysinger R, et al. Staged bilateral pallidotomy for treatment of Parkinson disease. J Neurosurg (2001) 94:437-44. doi:10.3171/jns.2001.94.3.0437.
27. Favre J, Burchiel KJ, Taha JM, Hammerstad J. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: patient assessment. Neurosurgery (2000) 46:344-53. doi:10.1097/00006123-200002000-00017.
28. Counihan TJ, Shinobu LA, Eskandar EN, Cosgrove GR, Penney JB Jr. Outcomes following staged bilateral pallidotomy in advanced Parkinson's disease. Neurology (2001) 56:799-802. doi:10.1212/WNL.56.6.799.
29. Parkin SG, Gregory RP, Scott R, Bain P, Silburn P, Hall B, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115 patients. Mov Disord (2002) 17:682-92. doi:10.1002/mds.10186.
30. Kumar R, Lozano AM, Montgomery E, Lang AE. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord (1998) 13:73-82.
31. Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, Staal MJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology (2004) 62:201-7. doi:10.1212/01.WNL.0000103235.12621.C3.
32. Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, van Laar T, et al. Long-term superiority of subthalamic nucleus stimulation over pallidotomy in Parkinson disease. Neurology (2009) 73:151-3. doi:10.1212/WNL.0b013e3181ad536c.
33. Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, DuffJ, Hutchinson WD, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 346:1383-7. doi:10.1016/S0140-6736(95)92404-3.
34. Kumar R, Lang AE, Rodriguez-Oroz MC, Lozano AM, Limousin P, Pollak P, et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology (2000) 55:S34-9.
35. Deep-Brain Stimulation for Parkinson's Disease Study Group X. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 345:956-63. doi:10.1056/NEJMoa000827.
36. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 128(Pt 10):2240-9. doi:10.1093/brain/awh571.
37. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 349:1925-34. doi:10.1056/NEJMoa035275.
38. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med (2010) 362:2077-91. doi:10.1056/NEJMoa0907083.
39. Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 79:55-65. doi:10.1212/WNL.0b013e31825dcdc1.
40. Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol (2013) 12:37-44. doi:10.1016/S1474-4422(12)70264-8.
41. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology (1999) 53:85-90. doi:10.1212/WNL.53.1.85.
42. Hooper AK, Okun MS, Foote KD, Fernandez HH, Jacobson C, Zeilman P, et al. Clinical cases where lesion therapy was chosen over deep brain stimulation. Stereotact Funct Neurosurg (2008) 86:147-52. doi:10.1159/000120426.
43. Munhoz RP, Teive HA, Francisco AN, Raskin S, Rogaeva E. Unilateral pallidotomy in a patient with parkinsonism and G2019S LRRK2 mutation. Mov Disord (2009) 24:791-2. doi:10.1002/mds.21818.
44. Terzic D, Abosch A. Update on deep brain stimulation for Parkinson's disease. J Neurosurg Sci (2012) 56:267-77.
45. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery (1994) 35:1126-9. doi:10.1227/00006123-199412000-00016.
46. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg (1998) 89:713-8. doi:10.3171/jns.1998.89.5.0713.
47. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol (2004) 55:871-5. doi:10.1002/ana.20091.
48. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 339:1105-11. doi:10.1056/NEJM199810153391603.
49. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain (1999) 122:1133-46. doi:10.1093/brain/122.6.1133.
50. Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesia in Parkinson's disease. Lancet (1997) 350:1676. doi:10.1016/S0140-6736(05)64273-0.
51. Oyama G, Foote KD, Jacobson CE IV, Velez-Lago F, Go C, Limotai N, et al. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease. Parkinsonism Relat Disord (2012) 18:814-8. doi:10.1016/j.parkreldis.2012.03.022.
52. Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 76:1640-4. doi:10.1136/jnnp.2005.063206.
53. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord (2006) 21(Suppl 14):S290-304. doi:10.1002/mds.20962.
54. Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Le Bas JF, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 43:180-92. doi:10.1002/ana.410430208.
55. Wu YR, Levy R, Ashby P, Tasker RR, Dostrovsky JO. Does stimulation of the GPi control dyskinesia by activating inhibitory axons? Mov Disord (2001) 16:208-16. doi:10.1002/mds.1046.
56. Bejjani B, Damier P, Arnulf I, Bonnet AM, Vidailhet M, Dormont D, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 49:1564-9. doi:10.1212/WNL.49.6.1564.
57. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 121:451-7. doi:10.1093/brain/121.3.451.
58. Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact Funct Neurosurg (2006) 84:176-9. doi:10.1159/000094957.
59. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain (2006) 129:1732-47. doi:10.1093/brain/awl127.
60. Saint-Cyr JA, Hoque T, Pereira LC, Dostrovsky JO, Hutchison WD, Mikulis DJ, et al. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg (2002) 97:1152-66. doi:10.3171/jns.2002.97.5.1152.
61. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 25:578-86. doi:10.1002/mds.22735.
62. Deuschl G, Paschen S, Witt K. Clinical outcome of deep brain stimulation for Parkinson's disease. Handb Clin Neurol (2013) 116C:107-28. doi:10.1016/B978-0-444-53497-2.00010-3.
63. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery (1999) 45:1375-82. doi:10.1097/00006123-199912000-00024.
64. St George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology (2010) 75:1292-9. doi:10.1212/WNL.0b013e3181f61329.
65. Munhoz RP, Werneck LC, Teive HA. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics. Clin Neurol Neurosurg (2010) 112:431-5. doi:10.1016/j.clineuro.2010.03.003.
66. Okun MS, Foote KD. Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother (2010) 10:1847-57. doi:10.1586/ern.10.156.
67. Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2011) 68:165. doi:10.1001/archneurol.2010.260.
68. Kumar R. Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia. Mov Disord (2002) 17:S198-207. doi:10.1002/mds.10164.
69. Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord (2002) 17:S181-7. doi:10.1002/mds.10162.
70. Tagliati M. Turning tables: should GPi become the preferred DBS target for Parkinson disease? Neurology (2012) 79:19-20. doi:10.1212/WNL.0b013e31825dce96.
71. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord (2002) 17:S188-97. doi:10.1002/mds.10163.
72. Mazzone P. Deep brain stimulation in Parkinson's disease: bilateral implantation of globus pallidus and subthalamic nucleus. J Neurosurg Sci (2003) 47: 47-51.
73. Deuschl G, Fogel W, Hahne M, Kupsch A, Müller D, Oechsner M, et al. Deep-brain stimulation for Parkinson's disease. J Neurol (2002) 249:III/36-9. doi:10.1007/s00415-002-1308-x.